{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T01:39:23Z","timestamp":1778895563441,"version":"3.51.4"},"reference-count":53,"publisher":"Wiley","issue":"s6","license":[{"start":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T00:00:00Z","timestamp":1098144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2004,11]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Symptom relief is one of the key goals in the management of gastric acid\u2010related disorders such as gastro\u2010oesophageal reflux disease (GERD), including nonerosive reflux disease (NERD), and duodenal and gastric ulcer. Whereas heartburn and regurgitation are classic symptoms of GERD, duodenal and gastric ulcers are associated with epigastric pain. The relationship between gastric acid and the presence of symptoms correlates well in GERD and duodenal ulcer, but not in gastric ulcer and NERD. Nevertheless, in all these disorders, gastric acid is considered a key pathogenic element, and acid suppression remains central to therapy. With their profound, prolonged effect on acid inhibition, proton pump inhibitors are considered the first\u2010choice therapy for these disorders. Rabeprazole is a newer generation proton pump inhibitor that suppresses the gastric proton pump and acid secretion more rapidly than does omeprazole, lansoprazole or pantoprazole. In clinical trial settings, rabeprazole provided fast and sustained symptom relief, which can help ensure patient acceptance of therapy and aid in patient compliance.<\/jats:p>","DOI":"10.1111\/j.1365-2036.2004.02162.x","type":"journal-article","created":{"date-parts":[[2004,10,19]],"date-time":"2004-10-19T15:24:57Z","timestamp":1098199497000},"page":"20-29","source":"Crossref","is-referenced-by-count":13,"title":["Review article: relief of symptoms in gastric acid\u2010related diseases \u2013 correlation with acid suppression in rabeprazole treatment"],"prefix":"10.1111","volume":"20","author":[{"given":"P.","family":"Miner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,10,19]]},"reference":[{"key":"e_1_2_15_2_2","first-page":"159","article-title":"pH, healing rate and symptom relief in acid\u2010related diseases","volume":"69","author":"Huang JQ","year":"1996","journal-title":"Yale J Biol Med"},{"key":"e_1_2_15_3_2","doi-asserted-by":"publisher","DOI":"10.1053\/gast.1997.v112.pm9178669"},{"issue":"4","key":"e_1_2_15_4_2","first-page":"17S","article-title":"Optimizing the pharmacology of acid control in acid\u2010related disorders","volume":"92","author":"Howden CW","year":"1997","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_15_5_2","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2001.09.1017"},{"key":"e_1_2_15_6_2","first-page":"S461","article-title":"An overview of gastroesophageal reflux disease. Based on a presentation by M. Michael Wolfe, MD","volume":"6","author":"Wolfe M","year":"2000","journal-title":"Am J Manag Care"},{"key":"e_1_2_15_7_2","first-page":"61","article-title":"The evaluation and treatment of adults with gastroesophageal reflux disease","volume":"50","author":"Flynn CA","year":"2001","journal-title":"J Fam Pract"},{"key":"e_1_2_15_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-200102000-00007"},{"key":"e_1_2_15_9_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409105365"},{"key":"e_1_2_15_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.159.7.649"},{"key":"e_1_2_15_11_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529409105369"},{"key":"e_1_2_15_12_2","doi-asserted-by":"publisher","DOI":"10.1159\/000200917"},{"key":"e_1_2_15_13_2","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jama.1996.03540120061035","article-title":"Gastroesophageal reflux disease","volume":"276","author":"Kahrilas PJ","year":"1996","journal-title":"JAMA"},{"key":"e_1_2_15_14_2","doi-asserted-by":"publisher","DOI":"10.1080\/00365520310002157"},{"key":"e_1_2_15_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.17.s1.6.x"},{"key":"e_1_2_15_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03600.x"},{"key":"e_1_2_15_17_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00856.x"},{"key":"e_1_2_15_18_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018822532736"},{"key":"e_1_2_15_19_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01181.x"},{"key":"e_1_2_15_20_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00438.x"},{"key":"e_1_2_15_21_2","doi-asserted-by":"publisher","DOI":"10.1080\/003655200453566"},{"key":"e_1_2_15_22_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2002.01207.x"},{"key":"e_1_2_15_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(02)04586-0"},{"issue":"1","key":"e_1_2_15_24_2","first-page":"A","article-title":"Rabeprazole 10 mg effectively controls symptoms of gastresophageal reflux disease (GERD) over 1 year","volume":"124","author":"Kristensen ES","year":"2003","journal-title":"Gastroenterology"},{"key":"e_1_2_15_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00837.x"},{"key":"e_1_2_15_26_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199800001-00026"},{"key":"e_1_2_15_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1590-8658(03)00267-6"},{"key":"e_1_2_15_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.07068.x"},{"key":"e_1_2_15_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.8.942"},{"key":"e_1_2_15_30_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0300-5089(21)00789-6","article-title":"Peptic ulceration and its correlation with symptoms","volume":"7","author":"Misiewicz JJ","year":"1978","journal-title":"Clin Gastroenterol"},{"key":"e_1_2_15_31_2","first-page":"41","article-title":"Acute relief of epigastric pain by antacid in duodenal ulcer patients","volume":"58","author":"Rune SJ","year":"1980","journal-title":"Scand J Gastroenterol Suppl"},{"key":"e_1_2_15_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.25.10.1113"},{"key":"e_1_2_15_33_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365528709090135"},{"key":"e_1_2_15_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1086-5802(16)31036-1"},{"key":"e_1_2_15_35_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00673.x"},{"key":"e_1_2_15_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00418.x"},{"key":"e_1_2_15_37_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00019.x"},{"key":"e_1_2_15_38_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.01933.x"},{"key":"e_1_2_15_39_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1999.00449.x"},{"key":"e_1_2_15_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2004.02029.x"},{"key":"e_1_2_15_41_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2003.01492.x"},{"key":"e_1_2_15_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0025-7125(16)30412-6"},{"key":"e_1_2_15_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-199110000-00007"},{"key":"e_1_2_15_44_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6090.795"},{"key":"e_1_2_15_45_2","first-page":"467","article-title":"Omeprazole and H2\u2010receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta\u2010analysis","volume":"7","author":"Eriksson S","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_15_46_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1998.00373.x"},{"key":"e_1_2_15_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2001.03511.x"},{"key":"e_1_2_15_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(03)00009-1"},{"key":"e_1_2_15_49_2","doi-asserted-by":"publisher","DOI":"10.3109\/00365529709011211"},{"key":"e_1_2_15_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1803"},{"key":"e_1_2_15_51_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00185.x"},{"key":"e_1_2_15_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9270(01)02777-0"},{"key":"e_1_2_15_53_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05769.x"},{"key":"e_1_2_15_54_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022812103923"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02162.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2036.2004.02162.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2036.2004.02162.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,27]],"date-time":"2023-09-27T10:52:26Z","timestamp":1695811946000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2036.2004.02162.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,19]]},"references-count":53,"journal-issue":{"issue":"s6","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["10.1111\/j.1365-2036.2004.02162.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2036.2004.02162.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,19]]}}}